212 related articles for article (PubMed ID: 14761505)
21. [Use of delayed-action beta-2 mimetics in the management of chronic obstructive bronchial diseases--for].
Muir JF; Cuvelier A
Rev Mal Respir; 1999 Jan; 16 Suppl 3():S75-6. PubMed ID: 10088257
[No Abstract] [Full Text] [Related]
22. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
Kurashima K; Hara K; Yoneda K; Kanauchi T; Kagiyama N; Tokunaga D; Takayanagi N; Ubukata M; Sugita Y
Respirology; 2009 Mar; 14(2):239-44. PubMed ID: 19210650
[TBL] [Abstract][Full Text] [Related]
23. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.
Nowak R; Emerman C; Hanrahan JP; Parsey MV; Hanania NA; Claus R; Schaefer K; Baumgartner RA;
Am J Emerg Med; 2006 May; 24(3):259-67. PubMed ID: 16635694
[TBL] [Abstract][Full Text] [Related]
24. [Respiratory apparatus and occupational noxae. A. Pneumoconiosis of coal miners. 2. Clinical studies on pneumoconiosis of coal miners].
Voisin C; Ribet M
Lille Med; 1971 Nov; 16(9):1237-41. PubMed ID: 5138693
[No Abstract] [Full Text] [Related]
25. [Acute effect of inhaled beta(2)-agonists with different type of intrinsic activity on airway resistance in healthy volunteers].
Kishimoto N; Ohnishi H; Fujita J; Kamei T; Tada S; Ueda N
Arerugi; 2004 Apr; 53(4):417-22. PubMed ID: 15187486
[TBL] [Abstract][Full Text] [Related]
26. [Influence of pulmonary function test on outcome of classification of impairment and disability for Stage I coal worker's pneumoconiosis].
He JL; Zhang QP; Zhao FY
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Jan; 25(1):30-1. PubMed ID: 17374185
[No Abstract] [Full Text] [Related]
27. The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma.
Hanania NA; Moore RH; Zimmerman JL; Miller CT; Bag R; Sharafkhaneh A; Dickey BF
Respir Med; 2007 May; 101(5):1007-14. PubMed ID: 17052901
[TBL] [Abstract][Full Text] [Related]
28. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
Tashkin DP
Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
[TBL] [Abstract][Full Text] [Related]
29. Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies.
Pinto Pereira LM; Clement Y; Rouse J; Matthew J; Asgarali Z; Ramoutar D; Teelucksingh S
Int J Clin Pharmacol Res; 2003; 23(2-3):69-74. PubMed ID: 15025036
[TBL] [Abstract][Full Text] [Related]
30. Effects of salmeterol in patients with persistent asthma receiving inhaled corticosteroid plus theophylline.
Inoue H; Komori M; Matsumoto T; Fukuyama S; Matsumura M; Nakano T; Tsuda M; Matsumoto K; Kanaya A; Moriwaki A; Aizawa H; Yoshida M; Nakanishi Y
Respiration; 2007; 74(6):611-6. PubMed ID: 16960440
[TBL] [Abstract][Full Text] [Related]
31. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study.
Pedersen SE; Bateman ED; Bousquet J; Busse WW; Yoxall S; Clark TJ;
J Allergy Clin Immunol; 2007 Nov; 120(5):1036-42. PubMed ID: 17935765
[TBL] [Abstract][Full Text] [Related]
32. [Methods for diagnosing the physiopathological mechanisms of bronchial obstruction].
Kuznetsova AG; Larin NV; Ivanov AV
Ter Arkh; 1996; 68(3):62-5. PubMed ID: 8744109
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of heart rate variability in coal miners with pneumoconiosis].
Li L; Zhao T; Yu YG; Xu CH; Wang YX; Liu SJ
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Jun; 22(3):222-3. PubMed ID: 15256165
[No Abstract] [Full Text] [Related]
34. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
Eguchi Y; Tateishi Y; Umeda N; Yoshikawa T; Kamoi H; Kanazawa H; Kudoh S; Hirata K; Fujimoto S
Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
[TBL] [Abstract][Full Text] [Related]
35. [Lung function and exercise tolerance after treatment with salmeterol or ipratropium bromide in chronic obstructive pulmonary disease].
Grzanka A; Pitsch T; Krzywiecki A; Rogala B
Pol Merkur Lekarski; 2004 Sep; 17(99):208-11. PubMed ID: 15628041
[TBL] [Abstract][Full Text] [Related]
36. [Pneumoconiosis in Kuzbass coal miners].
Potekhina VA; Kaplan LM
Ter Arkh; 1974; 46(12):121-2. PubMed ID: 4454010
[No Abstract] [Full Text] [Related]
37. The 24 h duration of bronchodilator action of the salmeterol/fluticasone combination inhaler.
Masoli M; Weatherall M; Ayling J; Williams M; Beasley R
Respir Med; 2005 May; 99(5):545-52. PubMed ID: 15823450
[TBL] [Abstract][Full Text] [Related]
38. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.
Stempel DA; Riedel AA; Carranza Rosenzweig JR
Curr Med Res Opin; 2006 Mar; 22(3):463-70. PubMed ID: 16574030
[TBL] [Abstract][Full Text] [Related]
39. [Agonists of the beta adrenergic receptors of the bronchial tree].
Pacheco CR
Gac Med Mex; 1981 Dec; 117(12):474-5. PubMed ID: 6123461
[No Abstract] [Full Text] [Related]
40. Pneumoconio-tuberculosis in soft coal miners: comparison of course, prognosis and physiologic impairment in non-miners with tuberculosis.
Young RC; De Ferrero E; Carr C; Montgomery WP; Hackney RL; Harden KA
J Natl Med Assoc; 1967 Mar; 59(2):81-9 passim. PubMed ID: 5341581
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
